|
|
Title: |
Trends in Ovarian Cancer Research |
Search Result:
| Edited by: |
A P Bardos |
| ISBN10-13: |
1594540233 : 9781594540233 |
| Format: |
Hardback |
| Pages: |
0 |
| Weight: |
.584 Kg. |
| Published: |
Nova Science Publishers, Inc (US) - July 2004 |
| List Price: |
146.99 Pounds Sterling |
| Availability: |
In Stock
Qty Available: 1 |
| Subjects: |
Oncology |
| Ovarian cancer is cancer that begins in the cells that constitute the ovaries, including surface epithelial cells, germ cells, and the sex cord-stromal cells. Cancer cells that metastasize from other organ sites to the ovary (most commonly breast or colon cancers) are not then considered ovarian cancer. According to the American Cancer Society, ovarian cancer accounts for 4 percent of all cancers among women and ranks fifth as a cause of their deaths from cancer. The American Cancer Society statistics for ovarian cancer estimate that there will be 25,400 new cases and 14,300 deaths in 2003. The death rate for this disease has not changed much in the last 50 years. Unfortunately, almost 70 percent of women with the common epithelial ovarian cancer are not diagnosed until the disease is advanced in stage -- i.e., has spread to the upper abdomen (stage III) or beyond (stage IV). The 5-year survival rate for these women is only 15 to 20 percent, whereas the 5-year survival rate for stage I disease patients approaches 90 percent and for stage II disease patients approaches 70 percent. Ovarian tumors are named according to the type of cells the tumor started from and whether the tumor is benign or cancerous. The three main types of ovarian tumors are: Epithelial Tumors, Germ Cell Tumors and Stromal Tumors. This new book brings together new and leading-edge research from around the world. |
| Table of Contents: |
| PARTIAL CONTENTS: Preface; The Value of Imaging in Ovarian Cancer (L. Balestreri, A. Morra, E. Borsatti, and S. Morassut, Centro Di Biferimento Oncologico, Italy); Tyrphostins and Retinoids Control Growth, erbB and RAR Expression in Ovarian Cancer Cells (Thomas W. Grunt, University Hospital, Austria); Possible Role of Hypoxia in Peritoneal Dissemination of Ovarian Cancer Cells: A Review (Akiko Horiuchi and Ikuo Konishi, Shinshu University School of Medicine, Japan); The Value of CA125 in the Management of Epithelial Ovarian Cancer (Hiroshi Tsuda, Osaka City General Hospital, Japan and Christina A. Bandera, Harvard Medical School); Circulating Markers (CA125, TPS, VEGF, sIL-2Ralpha) as Indicators of Different Biological Behavior of Ovarian Carcinomas (A. Harlozinska, P. Sedlaczek, M. Grybos, Wroclaw Medical University, Poland and I. Frydecka, Polish Academy of Science, Poland); Index. |
|
|
Item added to 
.png "Click here for catalogues")
